Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens

NCT07683000 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

590

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Lenacapavir
DRUG: Lenacapavir Tablet
DRUG: Teropavimab
DRUG: Zinlirvimab
DRUG: SBR

Sponsor

Gilead Sciences